NRT Smoking Cessation Aids in Brazil

NRT Smoking Cessation Aids in Brazil

  • September 2016
  • 22 pages
  • Euromonitor International
Report ID: 150146
NRT smoking cessation aids continued to perform well in 2016, registering current value growth of 15% to reach sales of B$163 million. This was a continuation of the very steady growth observed in the category throughout the review period. This strong growth can be at least partially attributed to the reduction seen in the number of smokers in the country, combined with an increase in the sales base from which the category is rising. According to the Brazilian Health Ministry, smoking prevalence...

Euromonitor International’s NRT Smoking Cessation Aids in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

NRT SMOKING CESSATION AIDS IN BRAZIL
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2011-2016
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
Table 4 Sales of NRT Gum by Flavour: % Value 2011-2016
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2012-2016
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2013-2016
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Executive Summary
Economic Slowdown Persists, Affecting Non-priority Categories More Intensely
Increasing Acceptance of Self-medication/self-care Due To Broadened Accessibility
Aggressive Pricing of Private Label Products Threatens the Competitiveness of Manufacturers
Sports Nutrition Manufacturers Expand Their Portfolios and Invest in Segmentation
Consumer Health Is Expected To Grow at A Slower Pace Over the Forecast Period
Key Trends and Developments
OTC Performs Relative Well During the Economic Slowdown As Growth Rates Slow
Health and Wellness Trend Dips As Prioritisation of Spending Negative Influences Sales of Vitamins and Dietary Supplements
Affordability Gains More Importance in the Strategies of Manufacturers
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 10 Life Expectancy at Birth 2011-2016
Market Data
Table 11 Sales of Consumer Health by Category: Value 2011-2016
Table 12 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 13 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 14 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=Brazil Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000